Cargando…
The role of CD4(+) T cells in tumor and chronic viral immune responses
Immunotherapies are mainly aimed to promote a CD8(+) T cell response rather than a CD4(+) T cell response as cytotoxic T lymphocytes (CTLs) can directly kill target cells. Recently, CD4(+) T cells have received more attention due to their diverse roles in tumors and chronic viral infections. In anti...
Autores principales: | Xie, Luoyingzi, Fang, Jingyi, Yu, Juncheng, Zhang, Weinan, He, Zhiqiang, Ye, Lilin, Wang, Huaizhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565399/ https://www.ncbi.nlm.nih.gov/pubmed/37829505 http://dx.doi.org/10.1002/mco2.390 |
Ejemplares similares
-
CD4(+) T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
por: Xiao, Minglu, et al.
Publicado: (2022) -
Low-Dose Albendazole Inhibits Epithelial-Mesenchymal Transition of Melanoma Cells by Enhancing Phosphorylated GSK-3β/Tyr216 Accumulation
por: He, Zhiqiang, et al.
Publicado: (2021) -
EZH2 restricts Tcf7 DNA methylation and promotes T(FH) differentiation during acute viral infection
por: Luo, Yuan, et al.
Publicado: (2022) -
Revealing the role of CD4(+) T cells in viral immunity
por: Sant, Andrea J., et al.
Publicado: (2012) -
The Transcription Factor T-Bet Is Required for Optimal Type I Follicular Helper T Cell Maintenance During Acute Viral Infection
por: Wang, Pengcheng, et al.
Publicado: (2019)